## IVZ: Invesco Ltd. - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 0.45 indicates fundamental undervaluation. Consistent execution (3/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($26.80)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Stock Traders Purchase Large Volume of Invesco Call Options (NYSE:IVZ)**
- Source: MarketBeat | 20260105T192121 | Bullish | Relevance: 100%
- Stock traders purchased an unusually high volume of Invesco (NYSE:IVZ) call options, indicating bullish sentiment, with 63,057 call options traded, a 1,330% increase from the average. This activity followed Invesco's Q3 earnings report where the company surpassed analyst expectations, reporting $0.61 EPS and $1.19 billion in revenue, leading to a 5.4% jump in stock price. Despite a consensus "Hold" rating from analysts, the stock shows strong recent performance and a dividend yield of approximately 3.0%.

**2. Invesco stock hits 52-week high at 27.48 USD By Investing.com**
- Source: Investing.com Canada | 20260105T152108 | Bullish | Relevance: 100%
- Invesco Ltd.'s stock has hit a new 52-week high of $27.48, reflecting significant investor confidence with a 58.49% return over the past year. Despite recent decreases in assets under management, the company has seen net long-term inflows and undertaken strategic changes like restructuring its QQQ Trust and partnering with LGT Capital Partners. Analysts remain optimistic, with BMO Capital raising its price target to $30.

**3. Invesco stock hits 52-week high at 27.48 USD**
- Source: Investing.com | 20260105T150827 | Bullish | Relevance: 100%
- Invesco Ltd.'s stock (IVZ) has reached a new 52-week high of $27.48, marking a significant milestone for the investment management company, with a current trading price of $27.58, slightly above its InvestingPro Fair Value estimate. The company has demonstrated substantial growth with a 58.49% one-year total return and a 64.05% return over the past six months, along with a healthy 3.12% dividend yield. Recent strategic moves, including the restructuring of the Invesco QQQ Trust and a partnership with LGT Capital Partners, indicate ongoing efforts to modernize offerings and strengthen market position.

**4. Olstein Capital Management L.P. Sells 77,120 Shares of Invesco Ltd. $IVZ**
- Source: MarketBeat | 20260103T133117 | Neutral | Relevance: 100%
- Olstein Capital Management L.P. significantly reduced its holdings in Invesco Ltd. by selling 77,120 shares in Q3, bringing their total stake to 304,000 shares valued at approximately $6.97 million. This comes after director Douglas J. Sharp also sold a substantial amount of stock. Despite insider selling, Invesco recently beat Q3 earnings estimates and declared a $0.21 quarterly dividend, while analysts maintain a "Hold" rating with a target price of $24.53.

**5. Form N-CSR Invesco India Exchange-T For: Oct 31**
- Source: StreetInsider | 20260105T110818 | Neutral | Relevance: 94%
- Invesco India Exchange-Traded Fund Trust has filed its Form N-CSR for the period ending October 31, 2025. The report details the Fund's performance, financial statements, and ongoing changes, including a planned shift in its underlying index, ticker symbol, and investment strategy to take effect in February 2026. The financial highlights indicate a net asset value total return of -1.25% for the year ended October 31, 2025, and expenses of 0.78% of average net assets.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 4, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Morgan Stanley | $28 | $27 | +4% |
| 2025-12-17 | Deutsche Bank | $31 | $26 | +19% |
| 2025-12-12 | Barclays | $28 | $25 | +12% |
| 2025-12-10 | BMO Capital | $30 | $28 | +7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Morgan Stanley | main | Equal-Weight |
| 2025-12-17 | Deutsche Bank | up | Buy |
| 2025-12-12 | Barclays | main | Equal-Weight |
| 2025-12-10 | BMO Capital | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 4 ($2.25M) |
| Sells | 4 ($4.39M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 60.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 3 |

**Top Holders:**
- Massachusetts Mutual: 18.3% (0.0%)
- Vanguard Group Inc: 11.7% (+1.1%)
- Blackrock Inc.: 8.5% (-16.7%)
- State Street Corpora: 4.8% (-3.3%)
- Dimensional Fund Adv: 4.8% (+1.5%)

### Key Risks

1. Insider selling cluster: $4.4M in recent transactions.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 4 raises (avg +11%) could attract flows.
- Momentum building: MRS_20 improving +3.4% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 0.45 indicates undervaluation relative to growth. Forward P/E 11.2x attractive for 27% earnings growth. Quality metrics strong (margin 17%). Analyst sentiment positive (4 raises, avg +11%). Institutional flow bullish (5 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $12.6B |
| Beta | 1.63 |
| 52W Range | $11.60 - $28.44 |
| Short Interest | 5.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.45 |
| Forward P/E | 11.2 |
| Current P/E | 14.2 |
| YoY Growth | 27.1% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from 1.9% to 5.3% (+3.4% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 88th percentile. MRS_5 at 4.4% confirms short-term momentum alignment. AM_20 at 5.5% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: +MTH (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 5.34% (CS: 89) | Strong |
| RSI_14 | 69.2 | Neutral |
| MACD Histogram | -0.02 | Bearish |
| vs SMA20 | 1.055x | Above |
| vs SMA50 | 1.132x | Above |
| vs SMA200 | 1.422x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $28.16
- **Stop Loss:** $26.80 (4.8% risk)
- **Target:** $30.88 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 1014
- **Position Value:** $28,554.24
- **Portfolio %:** 28.55%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-01-27 (Est: $0.57)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.44 | $0.61 | +37.7% |
| 2025Q2 | $0.40 | $0.36 | -10.7% |
| 2025Q1 | $0.39 | $0.44 | +13.9% |
| 2024Q4 | $0.47 | $0.52 | +9.6% |

---
*RULE-based L3 | 2026-01-07 09:36 | MRS_20*